Regencell Bioscience Holdings (Regencell Bioscience Holdings) Marketable Securities : $10.00 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Regencell Bioscience Holdings Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Regencell Bioscience Holdings's Marketable Securities for the quarter that ended in Jun. 2023 was $10.00 Mil.

Regencell Bioscience Holdings's annual Marketable Securities increased from Jun. 2021 ($0.00 Mil) to Jun. 2022 ($10.00 Mil) but then stayed the same from Jun. 2022 ($10.00 Mil) to Jun. 2023 ($10.00 Mil).

Regencell Bioscience Holdings Marketable Securities Historical Data

The historical data trend for Regencell Bioscience Holdings's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Marketable Securities Chart

Regencell Bioscience Holdings Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Marketable Securities

10.00

Regencell Bioscience Holdings Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Marketable Securities	Get a 7-Day Free Trial				-	-	10.00	-	10.00

Regencell Bioscience Holdings Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Regencell Bioscience Holdings (NAS:RGC) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Regencell Bioscience Holdings Marketable Securities Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG

Website

https://www.regencellbioscience.com

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.